Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-25-000144

EVP, Chief Scientific Officer sold 3,231 shares at $500.00 ($1,615,500)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ALTSHULER DAVID · EVP, Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-03-10 Sale : show line 1 in the form 10b5-1 −3,231 $500.00 $1,615,500 26,512 D
Open-market sales · 3,231 sh · avg $500.00 · $1,615,500
Loading xslF345X05/wk-form4_1741810093.xml…